The abstract is read at the publisher; the summary is JClub's.
In a UK multicenter trial of 172 hospitalized heart failure patients needing parenteral diuretics, early discharge with subcutaneous furosemide via a wearable minipump increased days alive and out of hospital by 4.0 days at 30 days.
- Why it matters: Prolonged intravenous diuretic treatment keeps many heart failure patients in hospital longer, raising inpatient cost and risk; an outpatient-capable approach could improve recovery time and reduce stays.
- What they did: Patients were randomized to early discharge using pH-neutral subcutaneous furosemide delivered by a patient-operated wearable minipump with review every 3 days, or usual care, with a 2-week clinic review; the primary endpoint was DAOH at 30 days.
- The result: Early discharge increased DAOH at 30 days by 4.0 days (95% CI 2.1–5.8; P < 0.001) and sustained a 4.2-day difference at 60 days, with shorter index hospitalization by 5.5 days and similar serious adverse event rates.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.